Author

Jacqueline Malvin

Scripps Research Institute

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Organism:rat· 1

Frequent Co-Authors

Aaron M. Barber-Axthelm· 1 shared Alireza Rahimi· 1 shared Amal Gebara-LambiD· 1 shared Anil K. Sen GuptaiD· 1 shared Armen Nazarian· 1 shared Arnab K. ChatterjeeiD· 1 shared Ashley K. Woods· 1 shared Carly A. DilleniD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Aaron M. Barber-Axthelm

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Orally Bioavailable SARS-CoV-2 Protease Inhibitors Bearing a Hydroxymethyl Ketone Warhead

N. G. R. Dayan Elshan, Karen C. Wolff, Frank O. Weiss, Sourav Ghorai, Gennadii A. Grabovyi, Katy Wilson, Laura Riva, Ashley K. Woods, James R. Pedroarena, Armen Nazarian, Yuyin Liu, Wrickban Mazumdar, Lirui Song, Neechi Okwor, Jacqueline Malvin, , Arnab K. Chatterjee

This paper describes the development of orally bioavailable SARS-CoV-2 protease inhibitors with a hydroxymethyl ketone warhead, showing improved potency and bioavailability compared to previous compounds.

Viruses · Jul 26, 2026Peer-reviewedPharmacology & Toxicology

Combining a rhesus cytomegalovirus/SIV vaccine with neutralizing antibody to protect against SIV challenge in rhesus macaques

Jessica D. Coppola, Mara Parren, Raiza B. Bastidas, Karen L. Saye-Francisco, Jacqueline Malvin, Joseph G. Jardine, Roxanne M. Gilbride, Sohita Ojha, Shana Feltham, David Morrow, Aaron M. Barber-Axthelm, Rachele M. Bochart, Randy L. Fast, Kelli A. Oswald, Rebecca S. Shoemaker, , Scott G. Hansen

This study shows combining a RhCMV/SIV vaccine with neutralizing antibodies enhances protection against SIV challenge in rhesus macaques.

Frontiers in Microbiology · Jun 2, 2025Peer-reviewedImmunology